CA2614631C - Compositions pharmaceutiques contenant des anticholinergiques et des corticosteroides sous la forme d'une suspension ou d'une solution inhalable - Google Patents

Compositions pharmaceutiques contenant des anticholinergiques et des corticosteroides sous la forme d'une suspension ou d'une solution inhalable Download PDF

Info

Publication number
CA2614631C
CA2614631C CA2614631A CA2614631A CA2614631C CA 2614631 C CA2614631 C CA 2614631C CA 2614631 A CA2614631 A CA 2614631A CA 2614631 A CA2614631 A CA 2614631A CA 2614631 C CA2614631 C CA 2614631C
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
composition according
present
propellant
inhalable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2614631A
Other languages
English (en)
Other versions
CA2614631A1 (fr
Inventor
Michel Pairet
Michael Paul Pieper
Christopher John Montague Meade
Richard Reichl
Christel Schmelzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10062712A external-priority patent/DE10062712A1/de
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Priority to CA2733294A priority Critical patent/CA2733294C/fr
Priority claimed from CA002436540A external-priority patent/CA2436540C/fr
Publication of CA2614631A1 publication Critical patent/CA2614631A1/fr
Application granted granted Critical
Publication of CA2614631C publication Critical patent/CA2614631C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

CA2614631A 2000-10-31 2001-10-23 Compositions pharmaceutiques contenant des anticholinergiques et des corticosteroides sous la forme d'une suspension ou d'une solution inhalable Expired - Fee Related CA2614631C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2733294A CA2733294C (fr) 2000-10-31 2001-10-23 Combinaison pharmaceutique constituee d'un sel de tiotropium et de ciclesonide

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10054042.2 2000-10-31
DE10054042 2000-10-31
DE10062712.9 2000-12-15
DE10062712A DE10062712A1 (de) 2000-12-15 2000-12-15 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
CA002436540A CA2436540C (fr) 2000-10-31 2001-10-23 Composition pharmaceutique a base d'anticholinergiques et de corticosteroides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002436540A Division CA2436540C (fr) 2000-10-31 2001-10-23 Composition pharmaceutique a base d'anticholinergiques et de corticosteroides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2733294A Division CA2733294C (fr) 2000-10-31 2001-10-23 Combinaison pharmaceutique constituee d'un sel de tiotropium et de ciclesonide

Publications (2)

Publication Number Publication Date
CA2614631A1 CA2614631A1 (fr) 2002-05-10
CA2614631C true CA2614631C (fr) 2011-06-14

Family

ID=39277211

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2614631A Expired - Fee Related CA2614631C (fr) 2000-10-31 2001-10-23 Compositions pharmaceutiques contenant des anticholinergiques et des corticosteroides sous la forme d'une suspension ou d'une solution inhalable

Country Status (1)

Country Link
CA (1) CA2614631C (fr)

Also Published As

Publication number Publication date
CA2614631A1 (fr) 2002-05-10

Similar Documents

Publication Publication Date Title
US7851483B2 (en) Medicaments comprising steroids and a novel anticholinergic
US20120189556A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
CA2431565C (fr) Nouvelles compositions pharmaceutiques a base d'anticholinergiques et de ciclesonide
US7994188B2 (en) Compounds for treating inflammatory diseases
CA2733294C (fr) Combinaison pharmaceutique constituee d'un sel de tiotropium et de ciclesonide
US20030018019A1 (en) Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
US6608054B2 (en) Pharmaceutical compositions based on anticholinergics and endothelin antagonists
US20090088408A1 (en) Pharmaceutical compositions on anticholinergics, corticosteroids and betamimetics
US20040010003A1 (en) Medicaments comprising betamimetics and a novel anticholinergic
US20020193392A1 (en) Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
IL155718A (en) Pharmaceutical preparations based on tiotropium salts and salmetrol salts
CA2568834A1 (fr) Medicaments pour inhalation comprenant des steroides et un anticholinergique
US20020122773A1 (en) Pharmaceutical compositions based on anticholinergics and dopamine agonists
CA2582207A1 (fr) Medicaments administres par inhalation contenant un anticholinergique, du salmeterol et un steroide du groupe ciclesonide ou mometasone furoate
WO2004024156A1 (fr) Sels de tiotropium utilises pour reduire le taux de mortalite respiratoire
US20020193394A1 (en) Compounds for treating inflammatory diseases
CA2481268C (fr) Medicaments comprenant des steroides et un nouvel anticholinergique
CA2534128C (fr) Combinaison d'un anticholinergique et d'un steroide et leur utilisation dans le traitement de troubles respiratoires par inhalation
CA2582153A1 (fr) Medicaments administres par inhalation contenant un nouvel anticholinergique, du formoterol et un steroide
CA2614631C (fr) Compositions pharmaceutiques contenant des anticholinergiques et des corticosteroides sous la forme d'une suspension ou d'une solution inhalable
CA2430592C (fr) Nouvelles compositions medicamenteuses a base d'anticholinergiques et d'agonistes de la dopamine
EP1654001A2 (fr) Medicament pour inhalation comprenant des steroides et un betamimetique
CA2533792C (fr) Medicaments d'inhalation contenant des steroides et des esters d'acide carboxylique de fluorene

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20201023